IDEXX LABORATORIES INC /DE OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
IDEXX LABORATORIES INC /DE (IDXX) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of $64.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-17.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2012-02-17
- IDEXX LABORATORIES INC /DE oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2011 was $64.00K, a 40.74% decline from fiscal 2010.
- IDEXX LABORATORIES INC /DE oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2010 was $108.00K, a 51.79% decline from fiscal 2009.
- IDEXX LABORATORIES INC /DE oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2009 was $224.00K, a 18.55% decline from fiscal 2008.
- IDEXX LABORATORIES INC /DE oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2008 was $275.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month |
|---|---|
| 2011-12-31 | $64.00K 10-K · filed 2012-02-17 |
| 2010-12-31 | $108.00K 10-K · filed 2012-02-17 |
| 2009-12-31 | $224.00K 10-K · filed 2012-02-17 |
| 2008-12-31 | $275.00K 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |